| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enzyme Inhibitors | 13 | 2022 | 609 | 3.040 |
Why?
|
| Methyltransferases | 9 | 2025 | 82 | 2.920 |
Why?
|
| Histones | 12 | 2022 | 573 | 2.190 |
Why?
|
| Antineoplastic Agents | 9 | 2025 | 1854 | 1.940 |
Why?
|
| Structure-Activity Relationship | 14 | 2025 | 611 | 1.620 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2022 | 567 | 1.610 |
Why?
|
| Antiviral Agents | 6 | 2025 | 824 | 1.510 |
Why?
|
| Histone Demethylases | 3 | 2017 | 44 | 1.490 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2021 | 236 | 1.270 |
Why?
|
| Histone-Lysine N-Methyltransferase | 9 | 2025 | 176 | 1.270 |
Why?
|
| Lysine | 5 | 2022 | 207 | 1.150 |
Why?
|
| Aldose-Ketose Isomerases | 3 | 2013 | 11 | 1.090 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2018 | 84 | 1.090 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 4 | 2025 | 75 | 1.000 |
Why?
|
| Leukemia | 2 | 2021 | 379 | 0.960 |
Why?
|
| Pyrazines | 2 | 2022 | 73 | 0.870 |
Why?
|
| Molecular Structure | 7 | 2021 | 320 | 0.860 |
Why?
|
| Acetamides | 1 | 2024 | 51 | 0.840 |
Why?
|
| Serine Endopeptidases | 2 | 2021 | 204 | 0.820 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2021 | 193 | 0.810 |
Why?
|
| Zika Virus | 2 | 2021 | 151 | 0.790 |
Why?
|
| Proteolysis | 2 | 2022 | 199 | 0.790 |
Why?
|
| Monoamine Oxidase Inhibitors | 3 | 2017 | 11 | 0.790 |
Why?
|
| Nuclear Proteins | 4 | 2025 | 1343 | 0.730 |
Why?
|
| Neoplasms | 4 | 2022 | 3038 | 0.710 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2021 | 39 | 0.690 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 91 | 0.690 |
Why?
|
| Wilms Tumor | 1 | 2022 | 119 | 0.690 |
Why?
|
| Cell Line, Tumor | 10 | 2025 | 3797 | 0.670 |
Why?
|
| Multienzyme Complexes | 2 | 2011 | 89 | 0.670 |
Why?
|
| Indoles | 1 | 2021 | 203 | 0.660 |
Why?
|
| Oxidoreductases | 2 | 2011 | 103 | 0.660 |
Why?
|
| Viral Proteins | 2 | 2021 | 360 | 0.650 |
Why?
|
| Cell Proliferation | 10 | 2025 | 2561 | 0.650 |
Why?
|
| Transcriptional Elongation Factors | 4 | 2025 | 30 | 0.650 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2019 | 40 | 0.610 |
Why?
|
| Zika Virus Infection | 1 | 2021 | 175 | 0.600 |
Why?
|
| Pyridines | 2 | 2020 | 250 | 0.590 |
Why?
|
| DNA Methylation | 2 | 2016 | 1147 | 0.590 |
Why?
|
| Norovirus | 4 | 2025 | 347 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2018 | 82 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 90 | 0.570 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 462 | 0.550 |
Why?
|
| Crystallography, X-Ray | 7 | 2024 | 394 | 0.540 |
Why?
|
| Gene Rearrangement | 2 | 2016 | 331 | 0.530 |
Why?
|
| Virus Replication | 4 | 2025 | 637 | 0.520 |
Why?
|
| Adenosine | 3 | 2016 | 140 | 0.500 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 363 | 0.490 |
Why?
|
| Thiohydantoins | 1 | 2015 | 4 | 0.490 |
Why?
|
| Peptide Hydrolases | 4 | 2023 | 149 | 0.490 |
Why?
|
| Glucocorticoids | 1 | 2018 | 403 | 0.470 |
Why?
|
| Drug Discovery | 3 | 2023 | 179 | 0.450 |
Why?
|
| Models, Molecular | 7 | 2021 | 1147 | 0.450 |
Why?
|
| Piperidines | 1 | 2015 | 240 | 0.430 |
Why?
|
| Pyridones | 3 | 2014 | 129 | 0.420 |
Why?
|
| Methylation | 5 | 2016 | 232 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 2578 | 0.400 |
Why?
|
| Toxoplasma | 1 | 2013 | 16 | 0.400 |
Why?
|
| Humans | 35 | 2025 | 134149 | 0.400 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 26 | 0.390 |
Why?
|
| Animals | 18 | 2025 | 36546 | 0.390 |
Why?
|
| Thiazoles | 1 | 2012 | 104 | 0.370 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2012 | 60 | 0.370 |
Why?
|
| Protease Inhibitors | 3 | 2025 | 100 | 0.360 |
Why?
|
| Organophosphonates | 1 | 2011 | 21 | 0.360 |
Why?
|
| Caliciviridae Infections | 4 | 2025 | 358 | 0.360 |
Why?
|
| Gastroenteritis | 3 | 2025 | 365 | 0.330 |
Why?
|
| Protein Conformation | 5 | 2021 | 873 | 0.330 |
Why?
|
| Kinetics | 3 | 2017 | 1357 | 0.320 |
Why?
|
| Chelating Agents | 1 | 2009 | 47 | 0.320 |
Why?
|
| Mice | 11 | 2025 | 19045 | 0.320 |
Why?
|
| Magnesium | 1 | 2009 | 127 | 0.310 |
Why?
|
| Neoplastic Stem Cells | 3 | 2018 | 352 | 0.310 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 2771 | 0.310 |
Why?
|
| Escherichia coli | 4 | 2019 | 1027 | 0.300 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2016 | 111 | 0.300 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 69 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2021 | 1741 | 0.290 |
Why?
|
| Cell Differentiation | 5 | 2020 | 2043 | 0.280 |
Why?
|
| Thermodynamics | 2 | 2019 | 145 | 0.270 |
Why?
|
| Gene Expression | 2 | 2022 | 1621 | 0.260 |
Why?
|
| Molecular Docking Simulation | 3 | 2023 | 127 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2016 | 1012 | 0.260 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2021 | 834 | 0.260 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 2174 | 0.260 |
Why?
|
| Apoptosis | 5 | 2018 | 1945 | 0.260 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 318 | 0.250 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2020 | 384 | 0.250 |
Why?
|
| Mice, SCID | 2 | 2018 | 615 | 0.240 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 407 | 0.240 |
Why?
|
| Mutation | 6 | 2019 | 6306 | 0.230 |
Why?
|
| Acetylation | 2 | 2022 | 195 | 0.220 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 149 | 0.220 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 20 | 0.220 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 475 | 0.210 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2023 | 36 | 0.210 |
Why?
|
| Viral Vaccines | 2 | 2025 | 345 | 0.210 |
Why?
|
| Blotting, Western | 2 | 2016 | 1140 | 0.200 |
Why?
|
| DNA | 2 | 2019 | 1681 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 266 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1331 | 0.190 |
Why?
|
| Acetyltransferases | 1 | 2022 | 92 | 0.190 |
Why?
|
| Histone Acetyltransferases | 1 | 2022 | 318 | 0.180 |
Why?
|
| Allosteric Regulation | 1 | 2021 | 64 | 0.180 |
Why?
|
| RNA Helicases | 1 | 2021 | 72 | 0.180 |
Why?
|
| Cyclohexanones | 1 | 2020 | 19 | 0.170 |
Why?
|
| Oncogenes | 1 | 2021 | 181 | 0.170 |
Why?
|
| Protein Binding | 3 | 2015 | 1858 | 0.170 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2020 | 14 | 0.170 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 191 | 0.160 |
Why?
|
| Dengue Virus | 1 | 2021 | 134 | 0.160 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 233 | 0.160 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2019 | 1 | 0.160 |
Why?
|
| West Nile virus | 1 | 2021 | 117 | 0.160 |
Why?
|
| Ubiquitination | 1 | 2020 | 185 | 0.160 |
Why?
|
| Calorimetry | 1 | 2019 | 63 | 0.160 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 276 | 0.160 |
Why?
|
| Sugars | 1 | 2019 | 17 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2022 | 364 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 385 | 0.150 |
Why?
|
| Ligands | 1 | 2020 | 572 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1157 | 0.150 |
Why?
|
| Glutarates | 2 | 2015 | 38 | 0.150 |
Why?
|
| Iron | 2 | 2019 | 305 | 0.140 |
Why?
|
| Substrate Specificity | 2 | 2015 | 313 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2019 | 564 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 128 | 0.140 |
Why?
|
| Monoamine Oxidase | 1 | 2017 | 13 | 0.140 |
Why?
|
| Acinetobacter baumannii | 2 | 2019 | 47 | 0.130 |
Why?
|
| Hematopoiesis | 1 | 2019 | 231 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 261 | 0.130 |
Why?
|
| Cyclopropanes | 1 | 2017 | 70 | 0.130 |
Why?
|
| Mice, Nude | 2 | 2016 | 780 | 0.130 |
Why?
|
| Naphthols | 1 | 2016 | 8 | 0.130 |
Why?
|
| U937 Cells | 1 | 2016 | 25 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2018 | 282 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 1106 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2016 | 242 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2014 | 627 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 890 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 250 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2023 | 1075 | 0.110 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 160 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 258 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 231 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2016 | 287 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 56 | 0.100 |
Why?
|
| Drug Repositioning | 1 | 2013 | 30 | 0.100 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2012 | 7 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 1102 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2025 | 178 | 0.100 |
Why?
|
| Klebsiella pneumoniae | 1 | 2013 | 88 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2014 | 377 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 546 | 0.100 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 97 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2014 | 837 | 0.100 |
Why?
|
| Disease | 1 | 2013 | 133 | 0.090 |
Why?
|
| Norwalk virus | 1 | 2013 | 170 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 90 | 0.090 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2011 | 15 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 168 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2019 | 2729 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1137 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 773 | 0.090 |
Why?
|
| Cell Movement | 1 | 2014 | 918 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 702 | 0.080 |
Why?
|
| beta-Lactamases | 1 | 2012 | 207 | 0.080 |
Why?
|
| Fosfomycin | 1 | 2009 | 2 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 873 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 77 | 0.080 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 45 | 0.080 |
Why?
|
| Gram-Positive Bacteria | 1 | 2009 | 49 | 0.080 |
Why?
|
| Gram-Negative Bacteria | 1 | 2009 | 74 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 825 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1440 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2014 | 871 | 0.080 |
Why?
|
| Antitubercular Agents | 1 | 2011 | 265 | 0.080 |
Why?
|
| Mitosis | 1 | 2009 | 205 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2911 | 0.070 |
Why?
|
| Cell Line | 2 | 2009 | 2859 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 408 | 0.070 |
Why?
|
| Galactose | 2 | 2019 | 57 | 0.060 |
Why?
|
| Crystallography | 1 | 2025 | 40 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 797 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2025 | 111 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 1383 | 0.050 |
Why?
|
| Polyproteins | 1 | 2021 | 8 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2020 | 57 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 47 | 0.040 |
Why?
|
| Transcription Factor AP-2 | 1 | 2020 | 23 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 102 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 2136 | 0.040 |
Why?
|
| Enterobactin | 1 | 2019 | 2 | 0.040 |
Why?
|
| Klebsiella | 1 | 2019 | 10 | 0.040 |
Why?
|
| Siderophores | 1 | 2019 | 10 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 463 | 0.040 |
Why?
|
| Female | 5 | 2020 | 71905 | 0.040 |
Why?
|
| Child | 2 | 2016 | 25869 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2019 | 218 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 151 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 822 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 606 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2016 | 37 | 0.030 |
Why?
|
| Virus Attachment | 1 | 2016 | 41 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2019 | 305 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 62 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 710 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 925 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 56 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2016 | 67 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 2016 | 194 | 0.030 |
Why?
|
| Interferons | 1 | 2016 | 145 | 0.030 |
Why?
|
| Genotype | 1 | 2021 | 2808 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2016 | 152 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1761 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 36 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 382 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2020 | 4934 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2014 | 35 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 1 | 2014 | 51 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 201 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 65 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 399 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 157 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 28 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2013 | 43 | 0.030 |
Why?
|
| Triazoles | 1 | 2014 | 142 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2013 | 69 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 198 | 0.030 |
Why?
|
| Epigenomics | 1 | 2014 | 195 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 131 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1594 | 0.020 |
Why?
|
| Estradiol | 1 | 2014 | 559 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 319 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 585 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 547 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 316 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2009 | 29 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 707 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 87 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 621 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2009 | 52 | 0.020 |
Why?
|
| Glioma | 1 | 2014 | 540 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3890 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 390 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 787 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4877 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6617 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1712 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1409 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4556 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 13220 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 14859 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 20625 | 0.010 |
Why?
|
| Male | 1 | 2014 | 66108 | 0.000 |
Why?
|